SK pharmteco will build $260M peptide production plant in Korea – Fierce Pharma

While most of South Korean CDMO SK pharmteco’s recent moves have been geared toward boosting its capacity to produce gene therapies, the company’s …

​While most of South Korean CDMO SK pharmteco’s recent moves have been geared toward boosting its capacity to produce gene therapies, the company’s …    Read More